LM

Laura Alexander M.D., M.S.

Executive Medical Director, Clinical Development at Elevar Therapeutics

Laura Alexander M.D., M.S. has worked as the Senior Medical Director of Clinical Development at Elevar Therapeutics since January 2023. Prior to this, they worked at Amicus Therapeutics as the Director of Clinical Research for Gene Therapy for Rare Diseases from January 2021 to February 2022.

Laura Alexander has a diverse education background. Laura earned their Medical Doctor (M.D.) degree in Clinical Medicine from the First Moscow State Medical University named after I.M. Sechenov. Additionally, they hold a Master of Science (M.S.) degree in Pharmacology from Thomas Jefferson University. Laura has recently attended the University of California, San Francisco to pursue further studies in Drug Development and Regulatory Sciences, though the specific degree obtained is not mentioned.

In addition to their formal education, Laura has obtained various certifications to enhance their skill set. Laura has a Certificate in Study Design and Research Methods from the University of Oxford, Department for Continuing Education. Moreover, they possess a Certificate in Communication for Professionals from the University of Pennsylvania. It is also noted that Laura is eligible for the US Medical Licensing Examination, according to the ECFMG (Educational Commission for Foreign Medical Graduates).

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Elevar Therapeutics

Elevar Therapeutics is a pharmaceutical company that specializes in the development of therapies for unmet medical needs in cancer. The company is developing two proprietary drug candidates; rivoceranib (Apatinib), a VEGFR-2 inhibitor which has demonstrated clinical efficacy in a variety of solid tumors and a BTK/JAK3 inhibitor with thepotential to treat hematologic malignancies and rheumatoid arthritis as an immunosuppressive agent.Elevar Therapeutics holds worldwide rights for rivoceranib excluding China and has partnered for development and marketing in South Korea.


Industries

Employees

11-50

Links